نتایج جستجو برای: dipyridamole test

تعداد نتایج: 813933  

Journal: :Archives of emergency medicine 1992
M Jahangiri D R Holdright

A case of myocardial infarction secondary to dipyridamole overdose is described in a 62-year-old woman with longstanding angina. Therapeutic doses of dipyridamole are associated with reversible myocardial ischaemia in a proportion of patients but serious adverse events are rare (Homma et al., 1987). To our knowledge this is the first reported case of dipyridamole overdose in the literature.

Journal: :Indian journal of medical sciences 2009
Rajesh Jacob

In our case, dipyridamole-induced ischemia is an unlikely cause. This may suggest the depressive action of dipyridamole through adenosine on the conducting system. We feel that dipyridamole is the probable cause of asystole in this individual, based on a score of 5 on Naranjo’s algorithm, and betablocking agents may have contributed to this.[6] In patients with underlying conduction abnormaliti...

Journal: :Physiological research 2004
A Wykretowicz A Filipiak A Szczepanik H Wysocki

Polymorphonuclear neutrophils (PMN) are thought to play a role in reperfusion injury and ischemia. These effects are partly mediated by toxic oxygen species (superoxide anion, hydrogen peroxide and hydroxyl radical) acting at the level of the endothelium. It was demonstrated recently that the superoxide anion reacts with nitric oxide (NO) and that interaction leads to the generation of highly t...

Journal: :Thrombosis research 1992
J P De la Cruz P J García F Sánchez de la Cuesta

Pyrogallol (a generator of superoxide anions) caused 50% increase in platelet aggregation induced by 400 microM of arachidonic acid. Dipyridamole did not produce a statistically significant inhibition of arachidonic-acid induced platelet aggregation, but it caused 100% inhibition of pyrogallol-stimulated platelet aggregation. Ferrous salts (Fe2+) induced 34% platelet aggregation which was inhib...

Journal: :Stroke 2003
E L L M De Schryver A Algra J van Gijn

BACKGROUND Patients enrolled in clinical trials after nondisabling cerebral ischemia have an annual risk of vascular events (death from all vascular causes, nonfatal stroke, or nonfatal myocardial infarction) of 4% to 11%. Aspirin reduces the incidence by 13%. Many trials in patients presenting with vascular disease investigated the efficacy of (addition of) dipyridamole in secondary prevention...

Journal: :Hypertension 1990
E Picano A R Lucarini F Lattanzi C Marini A Distante A Salvetti A L'Abbate

In asymptomatic patients with essential hypertension, electrocardiographic changes suggestive of myocardial ischemia can be elicited by rapid pressure lowering or by pronounced coronary arteriolar dilation. The aim of this study was to assess whether dipyridamole infusion might induce ischemic-like electrocardiographic changes in asymptomatic essential hypertensive patients and to describe the ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید